Poxel S.A. (EPA:POXEL)
0.7550
+0.0430 (6.04%)
May 30, 2025, 5:36 PM CET
Poxel Employees
Poxel had 6 employees as of December 31, 2023. The number of employees decreased by 31 or -83.78% compared to the previous year.
Employees
6
Change (1Y)
-31
Growth (1Y)
-83.78%
Revenue / Employee
€364,667
Profits / Employee
€2,684,167
Market Cap
40.52M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
EssilorLuxottica Société anonyme | 153,498 |
Sanofi | 82,878 |
Sartorius Stedim Biotech | 9,901 |
bioMérieux | 14,754 |
Eurofins Scientific SE | 62,696 |
Ipsen | 5,358 |
Virbac | 6,365 |
emeis Société anonyme | 83,494 |
Poxel News
- 3 days ago - New Clinical and Scientific Data on TWYMEEG® to be Presented at the 68th Annual Meeting of the Japan Diabetes Society - Benzinga
- 4 days ago - Poxel Announces Positive Preclinical Data for PXL065 in Hypertrophic Cardiomyopathy To Be Presented at the ESC Congress 2025 - Business Wire
- 17 days ago - Poxel S.A. reports Q1 results - Seeking Alpha
- 18 days ago - Poxel Reports Consolidated Revenue for the First Quarter 2025 and Provides Corporate Update - Business Wire
- 2 months ago - Poxel Announces Positive Results from a Preclinical Study for PXL065, a Proprietary Deuterium-Stabilized R-Stereoisomer of Pioglitazone, in Hypertrophic Cardiomyopathy - Business Wire
- 4 months ago - Poxel to receive sales-based payment and higher level of royalties from Sumitomo Pharma in Q1 2025 for TWYMEEG® Achieving JPY 5 billion Net Sales in Japan - Business Wire
- 7 months ago - Poxel Announces that its Annual General Meeting Will Be Held on November 28, 2024, at 9 am CET and the Availability of Preparatory Documents - Business Wire
- 8 months ago - Poxel SA (STU:7PO) Full Year 2023 Earnings Call Highlights: Strategic Moves and Financial Challenges - GuruFocus